Connect with us
Integrated oncology services Biologics would be the sole specialty provider of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s drug Iclusig. It would also be managing the Patient Access as...
Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) shares climbed 4.64% to $6.76. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines...
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares climbed 4.53% to $5.77 in the pre-market hour. The European Medicines Agency on Dec. 17 said it will review Ariad’s Iclusig...
Twitter Inc (NYSE:TWTR) shares dropped 1.67% to $55.51. On Dec. 16, Bob Peck from SunTrust downgraded shares of Twitter from Buy to Hold also as a...
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares climbed 12.69% to $4.32. Levi & Korsinsky on Dec. 5 announces that a class action lawsuit has been commenced in the...
Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) would be coming out with its quarterly earnings report soon and investors have witnessed the stock taking a hit due to bad news...